Seeking Alpha

Glenview Capital claims it does not intend to bid for Health Management (HMA +5.2%), which...

Glenview Capital claims it does not intend to bid for Health Management (HMA +5.2%), which recently adopted a poison pill apparently in response to Glenview's conversion of its Schedule 13G filing (disclosing a 14.6% stake) to a Schedule 13D. "We wish to clarify that [we] have made no proposals, either to HMA or to any of its holdings," Glenview says
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs